Table 2. Summary of measured p values.
| Comparison between response groups1 | Comparison over treatment time2 | |||||
|---|---|---|---|---|---|---|
| Week 1 | Week 4 | Week 8 | Pre-Op | R | NR | |
| p | p | |||||
| MBF | 0.413 | 0.000 | 0.000 | 0.020 | 0.000 | 0.474 |
| SI | 0.009 | 0.001 | 0.000 | 0.306 | 0.000 | 0.113 |
| SS | 0.222 | 0.275 | 0.116 | 0.375 | 0.161 | 0.127 |
| Hb | 0.375 | 0.002 | 0.000 | 0.000 | 0.000 | 0.005 |
| HbO2 | 0.000 | 0.001 | 0.000 | 0.000 | 0.000 | 0.015 |
| HbT | 0.004 | 0.000 | 0.000 | 0.000 | 0.000 | 0.003 |
| %Water | 0.495 | 0.008 | 0.062 | 0.001 | 0.000 | 0.241 |
| %Lipids | 0.838 | 0.000 | 0.000 | 0.000 | 0.000 | 0.595 |
| SP | 0.838 | 0.000 | 0.000 | 0.000 | 0.000 | 0.595 |
| SA | 0.410 | 0.002 | 0.002 | 0.001 | 0.000 | 0.170 |
| TOI | 0.339 | 0.000 | 0.000 | 0.000 | 0.000 | 0.058 |
A repeated-measures ANOVA was used to test for significant changes over time for QUS and DOSI parameters. QUS and DOS parameters were also tested for significant differences between responders and non-responders using an independent t-test within the 95% confidence level following a test for normality. Otherwise, a Mann-Whitney test was performed.
1
Independent t-test, tested for normality violations.
2
Repeated measures ANOVA.
p < 0.05, Considered statistically significant.
p < 0.01, Considered very statistically significant.